Refocus Group, Inc.·Healthcare
Refocus Group, Inc., a medical device company, engages in the research and development of treatments for human vision disorders, primarily for presbyopia. The company develops VisAbility Micro-Insert System, an investigational medical device that is in clinical trials for use in the binocular presbyopic treatment. It serves patients and eye care professionals. The company was founded in 1994 and is based in Dallas, Texas.
Healthcare
Medical - Devices
4
2003-03-07
-0.58

The AI company will combine ChatGPT, Codex app and browser in an effort to focus and streamline its resources.

GN Store Nord A/S (GNNDY) Discusses Sale of Hearing Business to Amplifon and Strategic Refocus on Technology Innovation Transcript

Deutsche Bank is upgraded to a buy, driven by positive macro forecasts and strong organic growth in loans and net asset inflows. DB benefits from sector tailwinds, improved operational efficiency, and a solid credit rating, despite lagging peers in profit margin and return on equity. Valuation remains below peers, reflecting justified caution due to DB's lower profitability and significant office CRE exposure; price forecast implies only 2% upside.